Beta-Hydroxybutyrate Augments Oxaliplatin-Induced Cytotoxicity by Altering Energy Metabolism in Colorectal Cancer Organoids
Deregulation of cellular metabolism has recently emerged as a notable cancer characteristic. This reprogramming of key metabolic pathways supports tumor growth. Targeting cancer metabolism demonstrates the potential for managing colorectal cancer. Beta-hydroxybutyrate (BOHB) acts as an acetyl-CoA so...
Main Authors: | Sever, Tolga, Ellidokuz, Ender Berat, Basbinar, Yasemin, Ellidokuz, Hulya, Yilmaz, Ömer H., Calibasi-Kocal, Gizem |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Published: |
Multidisciplinary Digital Publishing Institute
2023
|
Online Access: | https://hdl.handle.net/1721.1/153248 |
Similar Items
-
Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer
by: Urbanska, Aleksandra M., et al.
Published: (2015) -
An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment
by: Lim, Wei Qi, et al.
Published: (2020) -
In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis
by: Taylor, Martin S., et al.
Published: (2018) -
Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
by: Graf, Nora, et al.
Published: (2012) -
In-depth clinical and biological exploration of DNA damage immune response as a biomarker for oxaliplatin use in colorectal cancer
by: Malla, SB, et al.
Published: (2020)